Investor Relations

SciClone Pharmaceuticals (NASDAQ: SCLN) is a revenue-generating, China-centric, specialty pharmaceutical company with a substantial international business and a product portfolio of novel therapies for cancer and infectious diseases. The Company is focused on continuing sales growth and

... More »

pdf SciClone Corporate Presentation September 2014.

pdf China Regulatory and Commercialization Backgrounder

Recent Releases

Nov 10, 2014
SciClone Reports Financial Results for the Third Quarter 2014

Nov 6, 2014
SciClone to Present at Jefferies Global Healthcare Conference on November 19th

View all releases »

Events & Presentations

Nov 19, 2014 at 4:20 PM UK
Jefferies Global Healthcare Conference

Nov 10, 2014 at 4:30 PM ET
Q3 2014 SciClone Pharmaceuticals, Inc. Earnings

View all events & presentations »

Stock Chart
Stock price graph
3 Mo.   6 Mo.   1 Yr.
Stock Quote
SciClone Pharmaceuticals, Inc.
Price: 8.52
Change: + 0.05
Day High: 8.62
Day Low: 8.42
Volume: 383,800
Delayed at least 20 minutes.
Provided by eSignal.